case_images: PMC11289812_01
case_images: Peri-transplant timeline of calcineurin inhibitor neurotoxicity and graft-versus-host disease prophylaxis regimen. ATG: Antithymocyte globulin; Flu: fludarabine; Cy: cyclophosphamide; TBI: total body irradiation; PTCy: post-transplant cyclophosphamide; tac: tacrolimus: and CTLA4-Ig: cytotoxic T-lymphocyte-associated protein 4 Ig.
case_images: 10.1177_09636897241265249-fig1.jpg
case_images: PMC11289812_01_10.1177_09636897241265249-fig1.jpg
case_images: fig1-09636897241265249
case_images: Figure 1)  . For GVHD prophylaxis, he received PTCy and, on day +5, was started on MMF and tacrolimus continuous infusion of 1.5 mg IV every 24 h.
case_images: Chronic graft-versus-host disease (cGVHD) oropharynx lesion. Presenting buccal ulceration (A) and high-power view of the tongue biopsy with ulcerated squamous mucosa and scattered dyskeratotic cells with mixed acute and chronic inflammation, which raised the possibility of cGVHD (B).
case_images: 10.1177_09636897241265249-fig2.jpg
case_images: PMC11289812_01_10.1177_09636897241265249-fig2.jpg
case_images: fig2-09636897241265249
case_images: He did develop biopsy proven, moderate, steroid-responsive cGVHD limited to the oropharynx at day +187 (Figure 2).